Screening for pathogenic neuronal autoantibodies in serum and CSF of patients with first-episode psychosis
Translational Psychiatry Nov 13, 2021
Theorell J, Ramberger M, Harrison R, et al. - In first-episode psychosis (FEP) patients admitted to psychiatric care, formes frustes of autoimmune encephalitis were not prevalent. Screening for neuronal surface autoantibodies in unselected psychotic patients is not supported.
According to a hypothesis, a subgroup of patients with FEP suffer from a forme fruste of autoimmune encephalitis.
A prospectively ascertained clinically well-characterized cohort of 71 FEP patients without traditional neurological features, as well as 48 healthy controls, were included.
Testing of serum and cerebrospinal fluid (CSF) for autoantibodies against seven neuronal surface autoantigens was performed employing live cell-based assays.
These revealed 4% (3/71) patient sera with weak binding to either contactin-associated protein-like 2, the NMDAR (N-methyl-d-aspartate receptor) or glycine receptor vs no binding from 48 control samples (p = 0.28, Fisher’s test).
No CSF autoantibodies were detected in the three seropositive persons and they exhibited no differences from the autoantibody-negative patients in their clinical phenotypes, or across multiple parameters of peripheral and central inflammation.
For CSF NMDAR antibodies, all individuals were negative.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries